TET2 mutations frequently occur in the hematopoietic and immune systems, leading to myelodysplasia and related myeloid malignancies 178, and approximately 15% of myeloid cancers harbor somatic TET2 mutations 179. The gene discussed is TET2; the disease is myeloid neoplasm.